Lataa...
Anticancer therapy: boosting the bang of Bim
Even though activating mutations of B-Raf, a kinase atop the MAPK signaling cascade, reportedly sensitize tumor cells to MEK inhibitors, Raf and MEK inhibitors have exhibited limited clinical activity. In this issue of the JCI, Cragg et al. report that MEK inhibition upregulates the proapoptotic Bcl...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Clinical Investigation
2008
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2571037/ https://ncbi.nlm.nih.gov/pubmed/18949061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI37553 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|